Antifungal Agents
Candidemia
Candidiasis
Fluconazole
Meningitis, Cryptococcal

Fluconazole

Fluconazole is a member of the triazole family and stands as a cornerstone in the realm of antifungal agents, offering widespread therapeutic utility. This medication addresses a spectrum of fungal afflictions, including vaginal candidiasis, oropharyngeal and esophageal candidiasis, urinary tract infections, peritonitis, and systemic Candida infections. Its efficacy extends to candidemia, disseminated candidiasis, pneumonia, and cryptococcal meningitis. Beyond treatment of active disease, fluconazole serves a crucial prophylactic role, reducing the incidence of candidiasis in patients undergoing bone marrow transplantation subjected to cytotoxic chemotherapy or radiation therapy. This activity details the drug’s indications, mechanism of action, optimal dosing, noteworthy adverse effects, contraindications, monitoring parameters, and potential toxicity. Equipping healthcare providers with this understanding empowers them to navigate patient therapy effectively, fostering optimal outcomes in the battle against fungal infections.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.